Assessment of uterus position as a surrogate for high-risk clinical target volume with respect to the applicator position for multiple fractions of brachytherapy in cervical cancer
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, cilt.290, sa.6, ss.1201-1205, 2014 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 290 Sayı: 6
- Basım Tarihi: 2014
- Doi Numarası: 10.1007/s00404-014-3350-1
- Dergi Adı: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1201-1205
- Anahtar Kelimeler: High-dose-rate brachytherapy, Cervical cancer, Applicator (IU) position, HDR, RECOMMENDATIONS, RADIOTHERAPY, UTERINE, TERMS
- Hacettepe Üniversitesi Adresli: Evet
Özet
Hybrid magnetic resonance imaging/computerized tomography (MRI/CT) planning for high-dose-rate (HDR) brachytherapy in cervical cancer with MR/CT fusion for the first fraction followed by CT for fraction 2 and 3 is used at our center. The aim of this study is to evaluate the position of applicator intrauterine tube (IU) in relation to uterine serosa with each fraction of intracavitary high-dose-rate brachytherapy.